164 related articles for article (PubMed ID: 32171575)
1. The potential economic value of a therapeutic Chagas disease vaccine for pregnant women to prevent congenital transmission.
Bartsch SM; Stokes-Cawley OJ; Buekens P; Asti L; Bottazzi ME; Strych U; Wedlock PT; Mitgang EA; Meymandi S; Falcon-Lezama JA; Hotez PJ; Lee BY
Vaccine; 2020 Apr; 38(16):3261-3270. PubMed ID: 32171575
[TBL] [Abstract][Full Text] [Related]
2. A cost-effectiveness analysis of antenatal influenza vaccination among HIV-infected and HIV-uninfected pregnant women in South Africa.
Biggerstaff M; Cohen C; Reed C; Tempia S; McMorrow ML; Walaza S; Moyes J; Treurnicht FK; Cohen AL; Hutchinson P; Stoecker C; Steinberg J
Vaccine; 2019 Oct; 37(46):6874-6884. PubMed ID: 31575494
[TBL] [Abstract][Full Text] [Related]
3. Economic value of a therapeutic Chagas vaccine for indeterminate and Chagasic cardiomyopathy patients.
Bartsch SM; Bottazzi ME; Asti L; Strych U; Meymandi S; Falcón-Lezama JA; Randall S; Hotez PJ; Lee BY
Vaccine; 2019 Jun; 37(28):3704-3714. PubMed ID: 31104883
[TBL] [Abstract][Full Text] [Related]
4. The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America.
Lee BY; Bacon KM; Connor DL; Willig AM; Bailey RR
PLoS Negl Trop Dis; 2010 Dec; 4(12):e916. PubMed ID: 21179503
[TBL] [Abstract][Full Text] [Related]
5. The economic value of identifying and treating Chagas disease patients earlier and the impact on Trypanosoma cruzi transmission.
Bartsch SM; Avelis CM; Asti L; Hertenstein DL; Ndeffo-Mbah M; Galvani A; Lee BY
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006809. PubMed ID: 30395603
[TBL] [Abstract][Full Text] [Related]
6. The Public Health Benefits and Economic Value of Routine Yellow Fever Vaccination in Colombia.
Kieffer A; Hoestlandt C; Gil-Rojas Y; Broban A; Castañeda-Cardona C; Rosselli D
Value Health Reg Issues; 2019 Dec; 20():60-65. PubMed ID: 30974312
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of pneumococcal conjugate vaccination in Latin America and the Caribbean: a regional analysis.
Sinha A; Constenla D; Valencia JE; O'Loughlin R; Gomez E; de la Hoz F; Valenzuela MT; de Quadros CA
Rev Panam Salud Publica; 2008 Nov; 24(5):304-13. PubMed ID: 19141172
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of rotavirus vaccination in Albania.
Ahmeti A; Preza I; Simaku A; Nelaj E; Clark AD; Felix Garcia AG; Lara C; Hoestlandt C; Blau J; Bino S
Vaccine; 2015 May; 33 Suppl 1():A201-8. PubMed ID: 25919162
[TBL] [Abstract][Full Text] [Related]
9. Potential Clinical and Economic Value of Norovirus Vaccination in the Community Setting.
Bartsch SM; O'Shea KJ; Wedlock PT; Ferguson MC; Siegmund SS; Lee BY
Am J Prev Med; 2021 Mar; 60(3):360-368. PubMed ID: 33516583
[TBL] [Abstract][Full Text] [Related]
10. Mathematical models of cervical cancer prevention in Latin America and the Caribbean.
Goldie SJ; Diaz M; Constenla D; Alvis N; Andrus JK; Kim SY
Vaccine; 2008 Aug; 26 Suppl 11():L59-72. PubMed ID: 18945403
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of adding a birth dose of hepatitis B vaccine in the Dafra district of the Hauts-Bassins Region in Burkina Faso (NéoVac Study).
Gosset A; Diallo MY; Betsem E; Schaeffer L; Meda N; Vray M; Sombie R; Shimakawa Y; Boyer S
Vaccine; 2021 Jul; 39(33):4659-4670. PubMed ID: 34238606
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of dengue vaccination in ten endemic countries.
Zeng W; Halasa-Rappel YA; Baurin N; Coudeville L; Shepard DS
Vaccine; 2018 Jan; 36(3):413-420. PubMed ID: 29229427
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of norovirus vaccination in children in Peru.
Mirelman AJ; Ballard SB; Saito M; Kosek MN; Gilman RH
Vaccine; 2015 Jun; 33(27):3084-91. PubMed ID: 25980428
[TBL] [Abstract][Full Text] [Related]
14. Antenatal syphilis screening using point-of-care testing in low- and middle-income countries in Asia and Latin America: a cost-effectiveness analysis.
Kuznik A; Muhumuza C; Komakech H; Marques EM; Lamorde M
PLoS One; 2015; 10(5):e0127379. PubMed ID: 26010366
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of vaccinating children in Malawi with RTS,S vaccines in comparison with long-lasting insecticide-treated nets.
Seo MK; Baker P; Ngo KN
Malar J; 2014 Feb; 13():66. PubMed ID: 24564883
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa.
Kim SY; Russell LB; Park J; Verani JR; Madhi SA; Cutland CL; Schrag SJ; Sinha A
Vaccine; 2014 Apr; 32(17):1954-63. PubMed ID: 24530145
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of rotavirus vaccination in Argentina.
Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C
Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of Haemophilus influenzae type b (Hib) vaccine introduction in the universal immunization schedule in Haryana State, India.
Gupta M; Prinja S; Kumar R; Kaur M
Health Policy Plan; 2013 Jan; 28(1):51-61. PubMed ID: 22407018
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.
Patel HD; Roberts ET; Constenla DO
Vaccine; 2013 Dec; 31(51):6072-8. PubMed ID: 24176497
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia.
Sundaram N; Chen C; Yoong J; Luvsan ME; Fox K; Sarankhuu A; La Vincente S; Jit M
Vaccine; 2017 Feb; 35(7):1055-1063. PubMed ID: 28109706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
